Clinical trial · Interventional
Endoscopic Versus Conventional Parotidectomy for Benign Parotid Tumors
Endoscopic Versus Conventional Parotidectomy in the Management of Benign Parotid Tumors : A Prospective Comparative Study
NCT07600112CI-TRIAL-00112111miniparoactive not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare endoscopic and conventional parotidectomy in the management of benign parotid tumors regarding surgical outcomes, facial nerve preservation, operative time, postoperative complications, and cosmetic results, in order to evaluate the safety, feasibility, and potential advantages of the endoscopic minimally invasive technique.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Parotidectomy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Active Comparator Intervention Conventional Parotidectomy | Procedure | — | UNRESOLVED |
| Endoscopic Parotidectomy Group | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Endoscopic Parotidectomy Group
- description
- Experimental Arm Endoscopic Parotidectomy
- interventionNames
- Procedure: Endoscopic Parotidectomy Group
- type
- ACTIVE_COMPARATOR
- label
- Conventional Open Parotidectomy Group
- description
- Conventional Parotidectomy
- interventionNames
- Procedure: Active Comparator Intervention Conventional Parotidectomy
Primary outcomes (2)
- measure
- Surgical safety and feasibility
- timeFrame
- During surgery and up to 3 months postoperatively.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adults aged 18 years or older 2. Patients with benign parotid tumors involving the superficial lobe of the parotid gland 3. Tumors located in the inferior pole with or without limited deep lobe extension 4. Tumor size suitable for minimally invasive approach ≤4 cm 5. Patients fit for surgery under general anesthesia 6. Patients willing to provide informed consent and comply with follow-up Exclusion Criteria: 1. Recurrent parotid tumors 2. Previous parotid surgery on the affected side 3. Pre-existing facial nerve dysfunction 4. Previous neck surgery or extensive cervical/anterior chest wall scarring 5. Significant comorbidities contraindicating surgery or general anesthesia 6. Suspected or confirmed malignant parotid tumors
References
Publications (1)
- BACKGROUNDO'Brien CJ. Current management of benign parotid tumors--the role of limited superficial parotidectomy. Head Neck. 2003 Nov;25(11):946-52. doi: 10.1002/hed.10312. PMID 14603455